More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$10.13B
EPS
3.43
P/E ratio
26.3
Price to sales
0.74
Dividend yield
--
Beta
0.812312
Previous close
$90.39
Today's open
$90.68
Day's range
$89.56 - $91.69
52 week range
$61.95 - $92.18
show more
CEO
Stanley M. Bergman
Employees
25000
Headquarters
Melville, NY
Exchange
Nasdaq Global Select
Shares outstanding
111446542
Issue type
Common Stock
Healthcare
Medical Distributors
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • 21 hours ago

Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research • 19 hours ago

Is Henry Schein (HSIC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Sep 2, 2026

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Sep 2, 2026

HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors?
Zacks Investment Research • Aug 25, 2026

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Aug 21, 2026

Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?
Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.
Zacks Investment Research • Aug 19, 2026

HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
Zacks Investment Research • Aug 18, 2026

Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Aug 14, 2026

Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Aug 10, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Henry Schein Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.